ly3298176 tirzepatide mibavademab – EvoX Biotech Supplies LLC A Study of Tirzepatide ( LY3298176) – Tirzepatide (LY3298176) sodium | GIP/GLP-1

In SURMOUNT-1, which enrolled 2,539 adults with obesity, participants received tirzepatide at 5 mg, 10 mg, or 15 mg once weekly for 72 weeks

Clinical-trial dose ranges only no general-use protocols established

Do you feel at home in it

PubMed laboratory research record [PMID: 34942372] PubMed record related to this compound for laboratory literature review

Anti-inflammatory eating patterns Given that both Hashimoto's and metabolic dysfunction involve chronic inflammation, an anti-inflammatory dietary approach makes sense

Composition & Format Active components per vial: TB-500 10mg + BPC-157 10mg + GHK-Cu 50mg Total fill: 70 mg blue copper lyophilized powder Kit size: 10 vials/kit, tray-packed for export Consistent cap colors and batch coding to support visual stock control Key Features for Wholesale Buyers High-purity peptide blend manufactured in a China-based factory environment Blue copper appearance from GHK-Cu for easy identification in storage trays Peptide kits prepared for OEM / private-label projects on request Suitable for distributors needing regular, repeatable batch supply Packaging & Ordering Default configuration: 10 vials/kit in protective plastic trays Pouches, labels and outer cartons are packed for international transit and warehouse handling For current stock status, wholesale pricing and freight options, please contact us directly for a formal quotation Order processing and dispatch updates are generally available within 3 business days after payment confirmation Storage & Handling Store vials sealed at 28 C , protected from light and moisture Avoid repeated freezethaw cycles